Top Markets
#1 EXOD EXOD +22.08%
#2 Status Status +11.36%
#3 The Bitcoin Bull The Bitcoin Bull +5.66%
#4 Tornado Cash Tornado Cash +5.29%
#5 BCGame Coin BCGame Coin +5.00%
#6 B3 (Base) B3 (Base) +4.43%
#7 MarsCoin MarsCoin +3.79%
#8 Gas Gas +3.76%
#9 Fake World Assets Fake World Assets +3.61%
#10 The Black Bull The Black Bull +3.12%
Coin of the day
EXOD EXOD
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Covalon Technologies Ltd. Covalon Technologies Ltd.

Covalon Technologies Ltd.

COV
Kedudukan dalam Saham #25759
Covalon Technologies Ltd., a Canadian company based in Mississauga, innovates,... Covalon Technologies Ltd., a Canadian company based in Mississauga, innovates, develops, manufactures, and commercializes medical technologies and products globally. Its operations span major international markets, including North America, Europe, the Middle East, Asia, and Latin America, with licensing agreements in place. The company leverages three distinct proprietary technology platforms. Firstly, its collagen matrix platform underpins a family of products aimed at treating a variety of chronic and infected wounds, such as diabetic, pressure, and venous ulcers, as well as donor and graft sites, traumatic injuries healing by secondary intention, dehisced surgical wounds, and first- and second-degree burns. Secondly, an antimicrobial silicone adhesive platform is incorporated into pre- and post-surgical and vascular access products; these are specifically engineered to provide broad-spectrum antimicrobial protection by eliminating bacteria or yeast on contact. Thirdly, a unique medical coating platform employs a proprietary photo-polymerization process to generate active grafting sites, enabling the initiation and growth of new polymer chains directly on existing medical devices. Covalon's product portfolio, branded under "Covalon," encompasses advanced wound care dressings, surgical and peri-operative solutions, and infection management tools. These offerings reach a diverse clientele, including hospitals, specialized wound and burn centers, acute and long-term care facilities, home health care agencies, and physicians' offices, via a combination of direct sales and extensive third-party distribution networks.
Harga Saham
$1.69
Modal Pasaran
$46.62M
Perubahan (1 hari)
2.22%
Perubahan (1 tahun)
-18.69%
Negara
CA
Perdagangan Covalon Technologies Ltd. (COV)

Kategori

Healthcare
Pendapatan untuk Covalon Technologies Ltd. (COV)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Covalon Technologies Ltd., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Covalon Technologies Ltd. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US